Fremont, CA, United States of America

Roy Singfatt Chin

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 134(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):

Title: Roy Singfatt Chin: Innovator in Coronary Retroperfusion Technology

Introduction

Roy Singfatt Chin is a notable inventor based in Fremont, California. He has made significant contributions to the field of medical technology, particularly in the area of coronary retroperfusion. His innovative work aims to improve the treatment of ischemic myocardium, which is crucial for patients with heart conditions.

Latest Patents

Roy Singfatt Chin holds a patent for an "Apparatus for providing coronary retroperfusion and methods of use." This invention includes an apparatus and methods for perfusing ischemic myocardium, which can also help reduce the load on a patient's left ventricle. The apparatus features an inlet conduit designed for insertion into an oxygenated blood source, such as the left atrium or aorta, and is coupled to an outlet conduit for insertion into the coronary venous vasculature. The design includes a stylet or elastomeric sleeve for easier placement and a valve to limit peak pressure in the coronary venous system. Additionally, a motor-driven or hydraulically-actuated pump may be included to enhance functionality.

Career Highlights

Roy Singfatt Chin is currently associated with Medtronic Vascular, Inc., a leading company in medical technology. His work at Medtronic has allowed him to focus on developing innovative solutions that address critical health issues. His patent reflects his commitment to advancing medical technology and improving patient outcomes.

Collaborations

Throughout his career, Roy has collaborated with notable colleagues, including Ascher Shmulewitz and John H. Burton. These collaborations have likely contributed to the development and refinement of his innovative ideas.

Conclusion

Roy Singfatt Chin is a distinguished inventor whose work in coronary retroperfusion technology has the potential to significantly impact cardiac care. His patent demonstrates his dedication to improving medical treatments and enhancing patient health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…